Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3764518
Max Phase: Preclinical
Molecular Formula: C33H37N3O2
Molecular Weight: 507.68
Molecule Type: Small molecule
Associated Items:
ID: ALA3764518
Max Phase: Preclinical
Molecular Formula: C33H37N3O2
Molecular Weight: 507.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1nc2cc(-c3ccc(CCC4CCCCC4)cc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1
Standard InChI: InChI=1S/C33H37N3O2/c34-33-35-30-21-27(25-15-13-24(14-16-25)12-11-23-7-3-1-4-8-23)17-19-29(30)32(37)36(33)22-28-18-20-31(38-28)26-9-5-2-6-10-26/h2,5-6,9-10,13-17,19,21,23,28,31H,1,3-4,7-8,11-12,18,20,22H2,(H2,34,35)/t28-,31+/m0/s1
Standard InChI Key: APZCXJQGHVIROB-QCENPCRXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 507.68 | Molecular Weight (Monoisotopic): 507.2886 | AlogP: 7.08 | #Rotatable Bonds: 7 |
Polar Surface Area: 70.14 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 5.19 | CX LogP: 7.57 | CX LogD: 7.57 |
Aromatic Rings: 4 | Heavy Atoms: 38 | QED Weighted: 0.29 | Np Likeness Score: -0.07 |
1. Rasina D, Otikovs M, Leitans J, Recacha R, Borysov OV, Kanepe-Lapsa I, Domraceva I, Pantelejevs T, Tars K, Blackman MJ, Jaudzems K, Jirgensons A.. (2016) Fragment-Based Discovery of 2-Aminoquinazolin-4(3H)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV., 59 (1): [PMID:26670264] [10.1021/acs.jmedchem.5b01558] |
Source(1):